Table 1.
Patient characteristics.
| Number of cases | 140 |
|---|---|
| Gender, n (%), male : female | 61 : 79 (43.6 : 56.4) |
| Age, average ± SD | 72.1 ± 13.6 |
| Age distribution, n (%), ≤74 : ≥75 | 71 : 69 (50.7 : 49.3) |
| Laxative combination, n (%) | 76 (54.3) |
| Irritant laxative combination, n (%) | 34 (24.3) |
| Elobixibat dose (mg), n (%), 5 : 10 : 15 : discontinuation | 27 : 92 : 10 : 11 (19.3 : 65.7 : 7.1 : 7.9) |
| Underlying disease, n (%) | |
| Dyslipidemia | 42 (30.0) |
| Diabetes | 25 (17.9) |
| Hepatic disorder | 10 (7.1) |
| Hypothyroidism | 6 (4.3) |
| Parkinson's disease | 5 (3.6) |
| Concomitant medication, n (%) | |
| Antacids | 55 (39.3) |
| Antidepressants | 14 (10.0) |
| Calcium antagonists | 11 (7.9) |
| Parkinson's disease drugs | 5 (3.6) |
| Opioids | 4 (2.9) |
| Ursodeoxycholic acid | 3 (2.1) |
SD: standard deviation.